In Vivo's editors, along with experts from the Informa Pharma Intelligence team, have selected our top five picks for the most significant M&A, alliance and financing deals of 2022. Vote now in the polls below.
After much speculation, Amgen, Inc. acquired the Dublin-based biotech Horizon Therapeutics plc in a $27.8bn cash deal. It is thought Amgen was in a three-horse race alongsideSanofi...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?